JP1697931S - - Google Patents

Info

Publication number
JP1697931S
JP1697931S JPD2021-9496F JP2021009496F JP1697931S JP 1697931 S JP1697931 S JP 1697931S JP 2021009496 F JP2021009496 F JP 2021009496F JP 1697931 S JP1697931 S JP 1697931S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-9496F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of JP1697931S publication Critical patent/JP1697931S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-9496F 2020-11-17 2021-05-06 Active JP1697931S (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20200055545 2020-11-17

Publications (1)

Publication Number Publication Date
JP1697931S true JP1697931S (Direct) 2021-10-25

Family

ID=78118812

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-9496F Active JP1697931S (Direct) 2020-11-17 2021-05-06

Country Status (3)

Country Link
US (1) USD980453S1 (Direct)
JP (1) JP1697931S (Direct)
TW (1) TWD217304S (Direct)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1067673S1 (en) * 2023-05-19 2025-03-25 The Government of the United States of America, as represented by the Secretary of Homeland Security Testing items caddy
JP1791439S (ja) 2024-08-28 2025-02-19 細胞培養機
JP1791438S (ja) 2024-08-28 2025-02-19 細胞培養機

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD566851S1 (en) * 2007-06-20 2008-04-15 University Of Utah Research Foundation Disposable test tube rack
US9545629B2 (en) * 2013-10-24 2017-01-17 Canon Kabushiki Kaisha Micro flow-channel chip, method for manufacturing the same, and device for analysis
USD796562S1 (en) 2016-04-11 2017-09-05 Applied Materials, Inc. Plasma outlet liner
US20170341075A1 (en) * 2016-05-27 2017-11-30 Idex Health & Science Llc Methods and Apparatus for Coated Flowcells
USD812767S1 (en) * 2016-10-14 2018-03-13 Illumina, Inc. Flow cell cartridge
USD857229S1 (en) * 2017-01-03 2019-08-20 Illumina, Inc. Flowcell cartridge
USD857228S1 (en) * 2017-01-03 2019-08-20 Illumina, Inc. Full flowcell cartridge
USD851275S1 (en) * 2017-08-15 2019-06-11 Cellular Research, Inc. Cartridge
USD953574S1 (en) * 2019-11-25 2022-05-31 Illumina, Inc. Flow cell cartridge

Also Published As

Publication number Publication date
TWD217304S (zh) 2022-02-21
USD980453S1 (en) 2023-03-07

Similar Documents

Publication Publication Date Title
JP1697931S (Direct)
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134113A1 (es) Extracción directa de litio usando adsorbente de microingeniería
AR134114A1 (es) Modificadores covalentes de cisteína de akt1 y sus usos
AR134119A1 (es) Anticuerpos antifactor tisular y conjugados de anticuerpos, composiciones que comprenden anticuerpos antifactor tisular o conjugados de anticuerpos, y métodos para elaborar y utilizar anticuerpos antifactor tisular y conjugados de anticuerpos
AR134109A1 (es) Tapón de elevación
AR134110A1 (es) Inhibidores de ras
AR134105A1 (es) Compuestos de carbamoilpiridona tricíclicos en puente y usos de estos
AR134093A1 (es) Proteínas de unión a antígenos anti-cdh17 y sus usos
AR134104A1 (es) Compuestos de carbamoilpiridona tricíclicos en puente y usos de estos
AR134079A1 (es) Composiciones y métodos de unión a células t
AR134083A1 (es) Composiciones de anticuerpos biespecíficos contra dll3 humana y cd3 humana
AR134087A1 (es) Procesos para preparar inhibidores de kras